Related Experiment Video
Updated: Jul 20, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Improving School Experiences for Adolescents With Type 1 Diabetes
Saori S Kise1, Amanda Hopkins2, Sandra Burke3
1University of Iowa Hospitals and Clinics, 910 West Benton Street, Apartment 304 D, Iowa City, IA.
The Journal of School Health
|April 7, 2017
Summary
Schools can improve support for adolescents with type 1 diabetes (T1D) by addressing key challenges. Enhancing school environments and resources is crucial for better student experiences and outcomes.
Area of Science:
- Pediatric Endocrinology
- School Health Management
- Adolescent Health
Background:
- Type 1 diabetes (T1D) is a growing metabolic disease in children globally.
- Adolescents with T1D face unique management challenges in school settings.
- Optimizing the school environment is vital for T1D student well-being.
Purpose of the Study:
- To identify strategies for schools to foster positive environments for adolescents with T1D.
- To improve the experiences and health outcomes of students with T1D.
- To provide actionable insights for school health policies and practices.
Main Methods:
- An integrative literature review was conducted.
- Searches were performed in CINAHL and PubMed databases.
- 27 relevant articles were synthesized for this review.
Main Results:
- Key concerns include insufficient school nurses, limited teacher diabetes knowledge, and inadequate access to diabetes management tools.
- Students reported restricted self-care freedom, lack of nutritional information, and poor parent-school communication.
- Inconsistent school attendance due to T1D impacts academic achievement.
Conclusions:
- Specific implications for school nurses, teachers, and the overall school environment were identified.
- Recommendations focus on enhancing diabetes care support within educational institutions.
- Improving school-based support systems is essential for students with T1D.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...